Dealmaking in Europe’s life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength as companies respond to the stark realities of an aging population -
Earlier this...more
7/23/2025
/ Acquisitions ,
Artificial Intelligence ,
EU ,
European Commission ,
Healthcare ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Technology
Dealmaking in the pharma, medical and biotech (PMB) subsectors was driven by both old and new market trends in 2022 -
Following a ground-breaking year for dealmaking in 2021, global healthcare M&A remained robust in 2022,...more
1/25/2023
/ Acquisitions ,
Biotechnology ,
Cross-Border ,
Global Dealmaking ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
UK